Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Interferon-associated retinopathy]

T Hararda1, H Fukami, T Takeuchi

  • 1Augenklinik Fujita Health University Toyoake.

Klinische Monatsblatter Fur Augenheilkunde
|November 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effectiveness of polypharmacy measures consisting of a pharmacist check followed by a multidisciplinary team review in patients with poly-pharmacy admitted to a neurology ward.

Die Pharmazie·2025
Same author

Influence of object size on beam hardening in dual energy images: A study using different dual-energy CT systems.

Radiography (London, England : 1995)·2025
Same author

Contribution of the human cytochrome P450 2C subfamily to the metabolism of and the interactions with endogenous compounds including steroid hormones.

Die Pharmazie·2022
Same author

Effect of therapeutic plasma exchange on phenytoin plasma concentration in patients receiving intravenous fosphenytoin therapy.

Die Pharmazie·2020
Same author

An fMRI Study of the Brain Network Involved in Teeth Tapping in Elderly Adults.

Frontiers in aging neuroscience·2020
Same author

Pyogenic spondylitis with acute course caused by Corynebacterium simulans.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy·2019

Interferon therapy can cause retinopathy, a condition affecting vision, characterized by cotton-wool spots and splinter hemorrhages. This visual disturbance typically resolves, even with continued treatment.

Area of Science:

  • Ophthalmology
  • Oncology
  • Hepatology

Background:

  • Interferons are used for treating hepatitis C and certain cancers.
  • A novel interferon-associated retinopathy has emerged as a clinical concern.
  • This condition has not been previously documented in German-speaking regions.

Observation:

  • Four patients receiving interferon therapy developed retinopathy.
  • Clinical signs included cotton-wool spots and splinter hemorrhages.
  • Onset of retinopathy occurred within 5 to 30 days of initiating therapy.

Findings:

  • One patient experienced worsening retinopathy after a dose increase.
  • In two patients, retinopathy resolved despite ongoing interferon treatment.
  • The observed retinopathy appears to be a transient side effect.

Related Experiment Videos

Implications:

  • Interferon therapy requires careful ophthalmological monitoring.
  • Retinopathy may not necessitate treatment cessation.
  • Further research is needed to understand the pathogenesis and management of interferon-induced retinopathy.